News

OptimizeRx Expects Q4 2020 Revenue up 117% to Record $16 Million, Full Year up 75% to Record $43 Million

25 January 2021

ROCHESTER, Mich. – January 25, 2021 – OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, reported preliminary unaudited results for its fourth quarter and full year ended December 31, 2020.

Read press release here.

FIND US AT THE POINT OF CARE

WE INTEGRATE DIRECTLY INTO THE EHR

SCHEDULE A DEMO